Citations (45)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (17)
Ramón C. Hermida, Artemio Mojón, José R. Fernández, Ramón G. Hermida-Ayala, Juan J. Crespo, María T. Ríos, Manuel Domínguez-Sardiña, Alfonso Otero & Michael H. Smolensky. (2023) Elevated asleep blood pressure and non-dipper 24h patterning best predict risk for heart failure that can be averted by bedtime hypertension chronotherapy: A review of the published literature. Chronobiology International 40:1, pages 63-82.
Read now
Read now
Juan J. Crespo, Manuel Domínguez-Sardiña, Alfonso Otero, Ana Moyá, María T. Ríos, Elvira Sineiro, María C. Castiñeira, Pedro A. Callejas, Lorenzo Pousa, José L. Salgado, Carmen Durán & Juan J. Sánchez. (2020) The Hygia Project and Hygia Chronotherapy Trial: insights of we clinical investigators on the impact of the embedded continuing medical education on primary-care practice and improved patient cardiovascular health. Chronobiology International 37:5, pages 759-766.
Read now
Read now
José R. Fernández, Artemio Mojón & Ramón C. Hermida. (2020) Chronotherapy of hypertension: advantages of 48-h ambulatory blood pressure monitoring assessments in MAPEC and Hygia Chronotherapy Trial. Chronobiology International 37:5, pages 739-750.
Read now
Read now
Michael H. Smolensky, Ramon C. Hermida, Alain Reinberg, Linda Sackett-Lundeen & Francesco Portaluppi. (2016) Circadian disruption: New clinical perspective of disease pathology and basis for chronotherapeutic intervention. Chronobiology International 33:8, pages 1101-1119.
Read now
Read now
Ramón C. Hermida. (2016) Sleep-time ambulatory blood pressure as a prognostic marker of vascular and other risks and therapeutic target for prevention by hypertension chronotherapy: Rationale and design of the Hygia Project. Chronobiology International 33:7, pages 906-936.
Read now
Read now
Kristen Solocinski & Michelle L Gumz. (2015) Development of hypertension – clinical impact of dysregulation of circadian rhythms and implications for treatment. ChronoPhysiology and Therapy 5, pages 27-35.
Read now
Read now
Ramón C. Hermida, Michael H. Smolensky, Diana E. Ayala & Francesco Portaluppi. (2015) Ambulatory Blood Pressure Monitoring (ABPM) as the reference standard for diagnosis of hypertension and assessment of vascular risk in adults. Chronobiology International 32:10, pages 1329-1342.
Read now
Read now
Michael H. Smolensky, Diana E. Ayala & Ramon C. Hermida. (2015) Ambulatory Blood Pressure Monitoring (ABPM) as THE reference standard to confirm diagnosis of hypertension in adults: Recommendation of the 2015 U.S. Preventive Services Task Force (USPSTF). Chronobiology International 32:9, pages 1320-1322.
Read now
Read now
Ramón C. Hermida, Michael H. Smolensky, Diana E. Ayala, Francesco Portaluppi, Juan J. Crespo, Fabio Fabbian, Erhard Haus, Roberto Manfredini, Artemio Mojón, Ana Moyá, Luis Piñeiro, María T. Ríos, Alfonso Otero, Horia Balan & José R. Fernández. (2013) 2013 Ambulatory Blood Pressure Monitoring Recommendations for the Diagnosis of Adult Hypertension, Assessment of Cardiovascular and other Hypertension-associated Risk, and Attainment of Therapeutic Goals. Chronobiology International 30:3, pages 355-410.
Read now
Read now
Francesco Portaluppi, Erhard Haus & Michael H. Smolensky. (2013) Ambulatory Blood Pressure Monitoring: Killing the Elephant to Get Its Hair? No More, Please!. Chronobiology International 30:1-2, pages 1-5.
Read now
Read now
Ramón C. Hermida, Diana E. Ayala, José R. Fernández, Artemio Mojón, Michael H. Smolensky, Fabio Fabbian & Francesco Portaluppi. (2013) Administration-Time Differences in Effects of Hypertension Medications on Ambulatory Blood Pressure Regulation. Chronobiology International 30:1-2, pages 280-314.
Read now
Read now
Artemio Mojón, Diana E. Ayala, Luis Piñeiro, Alfonso Otero, Juan J. Crespo, Ana Moyá, Julia Bóveda, Jesús Pérez de Lis, José R. Fernández & Ramón C. Hermida. (2013) Comparison of Ambulatory Blood Pressure Parameters of Hypertensive Patients With and Without Chronic Kidney Disease. Chronobiology International 30:1-2, pages 145-158.
Read now
Read now
Ana Moyá, Juan J. Crespo, Diana E. Ayala, María T. Ríos, Lorenzo Pousa, Pedro A. Callejas, José L. Salgado, Artemio Mojón, José R. Fernández & Ramón C. Hermida. (2013) Effects of Time-of-Day of Hypertension Treatment on Ambulatory Blood Pressure and Clinical Characteristics of Patients With Type 2 Diabetes. Chronobiology International 30:1-2, pages 116-131.
Read now
Read now
Diana E. Ayala, Ana Moyá, Juan J. Crespo, Carmen Castiñeira, Manuel Domínguez-Sardiña,
Sonia Gomara, Elvira Sineiro, Artemio Mojón, María J. Fontao & Ramón C. Hermida. (2013) Circadian Pattern of Ambulatory Blood Pressure in Hypertensive Patients With and Without Type 2 Diabetes. Chronobiology International 30:1-2, pages 99-115.
Read now
Read now
Ramón C. Hermida, María T. Ríos, Juan J. Crespo, Ana Moyá, Manuel Domínguez-Sardiña, Alfonso Otero, Juan J. Sánchez, Artemio Mojón, José R. Fernández & Diana E. Ayala. (2013) Treatment-Time Regimen of Hypertension Medications Significantly Affects Ambulatory Blood Pressure and Clinical Characteristics of Patients With Resistant Hypertension. Chronobiology International 30:1-2, pages 192-206.
Read now
Read now
Juan J. Crespo, Luis Piñeiro, Alfonso Otero, Carmen Castiñeira, María T. Ríos, Antonio Regueiro, Artemio Mojón, Sonia Lorenzo, Diana E. Ayala & Ramón C. Hermida. (2013) Administration-Time-Dependent Effects of Hypertension Treatment on Ambulatory Blood Pressure in Patients With Chronic Kidney Disease. Chronobiology International 30:1-2, pages 159-175.
Read now
Read now
Cristina Crespo, José R. Fernández, Mateo Aboy & Artemio Mojón. (2013) Clinical Application of a Novel Automatic Algorithm for
Actigraphy-Based Activity and Rest Period Identification to
Accurately Determine Awake and Asleep Ambulatory Blood Pressure Parameters and Cardiovascular Risk. Chronobiology International 30:1-2, pages 43-54.
Read now
Read now
Articles from other publishers (28)
J. Mesquita Bastos, Lisa Ferraz, Flávio G. Pereira & Susana Lopes. (2023) Systolic Blood Pressure and Pulse Pressure Are Predictors of Future Cardiovascular Events in Patients with True Resistant Hypertension. Diagnostics 13:10, pages 1817.
Crossref
Crossref
Raija Lithovius & Per-Henrik Groop. (2023) The many faces of hypertension in individuals with type 1 diabetes. Diabetes Research and Clinical Practice 197, pages 110564.
Crossref
Crossref
Xuelei Zhang, Ling Xu, Peiyi Zhou, Dongqi Song, Jian Wu & Lifang Jia. (2021) Intradialytic BP variability is associated with cardiovascular mortality and hospitalization in HD patients. Therapeutic Apheresis and Dialysis 26:3, pages 624-631.
Crossref
Crossref
Michael H Smolensky, Ramon C Hermida & Yong-Jian Geng. (2021) Chronotherapy of cardiac and vascular disease: timing medications to circadian rhythms to optimize treatment effects and outcomes. Current Opinion in Pharmacology 57, pages 41-48.
Crossref
Crossref
Ramón C. Hermida, Ramón G. Hermida-Ayala, Michael H. Smolensky, Artemio Mojón & José R. Fernández. (2021) Ingestion-time differences in the pharmacodynamics of hypertension medications: Systematic review of human chronopharmacology trials. Advanced Drug Delivery Reviews 170, pages 200-213.
Crossref
Crossref
Richard Chia, Ambarish Pandey & Wanpen Vongpatanasin. (2020) Resistant hypertension-defining the scope of the problem. Progress in Cardiovascular Diseases 63:1, pages 46-50.
Crossref
Crossref
Ramón C. Hermida, Diana E. Ayala, José R. Fernández, Artemio Mojón & Michael H. Smolensky. (2018) Hypertension: New perspective on its definition and clinical management by bedtime therapy substantially reduces cardiovascular disease risk. European Journal of Clinical Investigation 48:5.
Crossref
Crossref
Erum Z. Malik, Basma Abdulhadi, Kenechukwu N. Mezue, Edgar V. Lerma & Janani Rangaswami. (2018) Clinical hypertension: Blood pressure variability. Disease-a-Month 64:1, pages 5-13.
Crossref
Crossref
Michael H. Smolensky, Ramón C. Hermida, Diana E. Ayala, Artemio Mojón & José R. Fernández. (2017) Bedtime Chronotherapy with Conventional Hypertension Medications to Target Increased Asleep Blood Pressure Results in Markedly Better Chronoprevention of Cardiovascular and Other Risks than Customary On-awakening Therapy. Heart Failure Clinics 13:4, pages 775-792.
Crossref
Crossref
Ramón C. Hermida, Diana E. Ayala, José R. Fernández, Artemio Mojón, Juan J. Crespo, María T. Ríos & Michael H. Smolensky. (2017) Bedtime Blood Pressure Chronotherapy Significantly Improves Hypertension Management. Heart Failure Clinics 13:4, pages 759-773.
Crossref
Crossref
Ramón C. Hermida, Diana E. Ayala, Michael H. Smolensky, José R. Fernández, Artemio Mojón & Francesco Portaluppi. (2017) Sleep-time blood pressure: Unique sensitive prognostic marker of vascular risk and therapeutic target for prevention. Sleep Medicine Reviews 33, pages 17-27.
Crossref
Crossref
Raúl Fernández-Prado, Esmeralda Castillo-Rodríguez & Alberto Ortiz. 2017. Resistant Hypertension in Chronic Kidney Disease. Resistant Hypertension in Chronic Kidney Disease
183
193
.
Romance Nguetse Djoumessi, Jean Jacques N. Noubiap, Francois Folefack Kaze, Mickael Essouma, Alain Patrick Menanga, Andre Pascal Kengne, Jean Claude Mbanya & Eugene Sobngwi. (2016) Effect of low-dose spironolactone on resistant hypertension in type 2 diabetes mellitus: a randomized controlled trial in a sub-Saharan African population. BMC Research Notes 9:1.
Crossref
Crossref
Jordana B. Cohen & Debbie L. Cohen. (2016) Integrating Out-of-Office Blood Pressure in the Diagnosis and Management of Hypertension. Current Cardiology Reports 18:11.
Crossref
Crossref
Ramón C Hermida, Diana E Ayala, Michael H Smolensky, José R Fernández, Artemio Mojón & Francesco Portaluppi. (2015) Chronotherapy with conventional blood pressure medications improves management of hypertension and reduces cardiovascular and stroke risks. Hypertension Research 39:5, pages 277-292.
Crossref
Crossref
Ramón C. Hermida, Diana E. Ayala, Michael H. Smolensky & Francesco Portaluppi. 2016. Circadian Clocks: Role in Health and Disease. Circadian Clocks: Role in Health and Disease
295
334
.
Ramón C. Hermida, Ana Moyá & Diana E. Ayala. (2015) Monitorización ambulatoria de la presión arterial en diabetes para valoración y control de riesgo vascular. Endocrinología y Nutrición 62:8, pages 400-410.
Crossref
Crossref
Ramón C. Hermida, Ana Moyá & Diana E. Ayala. (2015) Ambulatory blood pressure monitoring in diabetes for the assessment and control of vascular risk. Endocrinología y Nutrición (English Edition) 62:8, pages 400-410.
Crossref
Crossref
Vladislava Zohdi, Kyungjoon Lim, James Pearson & M. Black. (2014) Developmental Programming of Cardiovascular Disease Following Intrauterine Growth Restriction: Findings Utilising A Rat Model of Maternal Protein Restriction. Nutrients 7:1, pages 119-152.
Crossref
Crossref
José Boggia, Ricardo Silvariño, Leonella Luzardo & Oscar Noboa. (2014) Significance of white-coat and masked hypertension in chronic kidney disease and end-stage renal disease. Hypertension Research 37:10, pages 882-889.
Crossref
Crossref
Michel Burnier & Gregoire Wuerzner. (2014) Ambulatory Blood Pressure and Adherence Monitoring: Diagnosing Pseudoresistant Hypertension. Seminars in Nephrology 34:5, pages 498-505.
Crossref
Crossref
Ramón C. Hermida, Diana E. Ayala, María T. Ríos, José R. Fernández, Artemio Mojón & Michael H. Smolensky. (2014) Around-the-clock Ambulatory Blood Pressure Monitoring is Required to Properly Diagnose Resistant Hypertension and Assess Associated Vascular Risk. Current Hypertension Reports 16:7.
Crossref
Crossref
Franz Weber & Manfred Anlauf. (2014) Treatment Resistant Hypertension. Deutsches Ärzteblatt international.
Crossref
Crossref
Ramón C. Hermida, Diana E. Ayala, Michael H. Smolensky, José R. Fernández, Artemio Mojón, Juan J. Crespo, María T. Ríos, Ana Moyá & Francesco Portaluppi. (2014) Chronotherapeutics of Conventional Blood Pressure-Lowering Medications: Simple, Low-Cost Means of Improving Management and Treatment Outcomes of Hypertensive-Related Disorders. Current Hypertension Reports 16:2.
Crossref
Crossref
Tetsuo Nishikawa, Masao Omura, Jun Saito & Yoko Matsuzawa. (2013) The possibility of resistant hypertension during the treatment of hypertensive patients. Hypertension Research 36:11, pages 924-929.
Crossref
Crossref
Christina S. Oxlund, Jan E. Henriksen, Lise Tarnow, Karoline Schousboe, Jeppe Gram & Ib A. Jacobsen. (2013) Low dose spironolactone reduces blood pressure in patients with resistant hypertension and type 2 diabetes mellitus. Journal of Hypertension 31:10, pages 2094-2102.
Crossref
Crossref
Nayan Desai, Vishnupriya Madhavankutty Saraswathy, Krystal Hunter & Christopher McFadden. (2013) Prevalence of True Therapeutic Inertia in Blood Pressure Control in an Academic Chronic Kidney Disease Clinic. The Journal of Clinical Hypertension 15:6, pages 375-379.
Crossref
Crossref
Ramón C. Hermida, Diana E. Ayala, Michael H. Smolensky, Artemio Mojón, José R. Fernández, Juan J. Crespo, Ana Moyá, María T. Ríos & Francesco Portaluppi. (2013) Chronotherapy improves blood pressure control and reduces vascular risk in CKD. Nature Reviews Nephrology 9:6, pages 358-368.
Crossref
Crossref